JCHOR

The Journal of Current Hematology & Oncology Research regularly publishes internationally qualified research in hematology and oncology within the current scholarly knowledge. This journal is indexed by indices that are considered international scientific journal indices (DRJI, ESJI, OAJI, etc.). According to the current Associate Professorship criteria, it is within the scope of International Article 1-d. Each article published in this journal corresponds to 5 points.

EndNote Style
ViewAll

Cover and Contents

Full Issue

Original Article - Hematology

Effect of tyrosine kinase inhibitor and conventional chemotherapy on COVID 19 antibody level in hematological patients

: 405 : 243

Citation : Kaya A, Berber İ, Kuku İ, et al. Effect of tyrosine kinase inhibitor and conventional chemotherapy on COVID-19 antibody level in hematological patients. J Curr Hematol Oncol Res. 2023; 1(1): 1-4

Original Article - Oncology

: 249 : 249

Citation : Genç M, Yalçın S, Kısa Ü. The evaluation of presepsin level and bacterial infection in neutropenic patients. JCHOR. 2023;1(1):.

Review - Oncology

Tumor markers: when, whom?

: 231 : 278

Citation : Varlıbaş A, Çifci A. Tumor markers: when, whom?. J Curr Hematol Oncol Res. 2023; 1(1): 9-11

Case Report - Hematology

A case of malignant melanoma presented with lombar vertebra fracture

: 285 : 200

Citation : Sarıcı A, Kuku İ, Berber İ, et al. A case of malignant melanoma presented with lumbar vertebra fracture. J Curr Hematol Oncol Res. 2023; 1(1): 12-14

Case Report - Hematology

A case of dapsone-induced hemolytic anemia related to G6PD enzyme deficiency

: 239 : 248

Citation : Doğan A, Yıldırım Doğan N, Ekinci Ö, et al. A case of dapsone-induced hemolytic anemia related to G6PD enzyme deficiency. J Curr Hematol Oncol Res. 2023; 1(1): 15-17
_Footer